Greenleaf Trust Has $15.12 Million Stock Position in Procter & Gamble Company (The) $PG

Key Points

• Greenleaf Trust reduced its holdings in Procter & Gamble by 10.7% in Q2, ending with a value of $15.12 million after selling 11,432 shares.
• Insider trading has been notable, with CEO Sundar G. Raman selling 9,554 shares for approximately $1.51 million, which decreased his ownership by 18.57%.
• Analyst ratings indicate a diverse outlook with an average target price of $173.68, supported by multiple buy ratings from various institutions.

Greenleaf Trust lessened its holdings in Procter & Gamble Company (The) (NYSE:PG - Free Report) by 10.7% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 94,916 shares of the company's stock after selling 11,432 shares during the period. Greenleaf Trust's holdings in Procter & Gamble were worth $15,122,000 at the end of the most recent quarter.

A number of other hedge funds have also added to or reduced their stakes in PG. Nova Wealth Management Inc. bought a new stake in Procter & Gamble during the first quarter worth $26,000. Signature Resources Capital Management LLC boosted its holdings in Procter & Gamble by 67.9% during the 2nd quarter. Signature Resources Capital Management LLC now owns 178 shares of the company's stock worth $28,000 after acquiring an additional 72 shares during the last quarter. Quarry LP bought a new stake in shares of Procter & Gamble in the 1st quarter worth $33,000. Mizuho Securities Co. Ltd. grew its stake in shares of Procter & Gamble by 566.7% in the 1st quarter. Mizuho Securities Co. Ltd. now owns 200 shares of the company's stock worth $34,000 after acquiring an additional 170 shares in the last quarter. Finally, Quest 10 Wealth Builders Inc. raised its holdings in shares of Procter & Gamble by 50.3% in the first quarter. Quest 10 Wealth Builders Inc. now owns 245 shares of the company's stock valued at $42,000 after purchasing an additional 82 shares during the last quarter. Institutional investors and hedge funds own 65.77% of the company's stock.

Insider Activity

In other news, CEO Sundar G. Raman sold 9,554 shares of the firm's stock in a transaction on Thursday, August 21st. The stock was sold at an average price of $158.16, for a total value of $1,511,060.64. Following the completion of the transaction, the chief executive officer directly owned 41,886 shares of the company's stock, valued at $6,624,689.76. This trade represents a 18.57% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, insider Susan Street Whaley sold 1,000 shares of Procter & Gamble stock in a transaction on Friday, August 29th. The shares were sold at an average price of $156.84, for a total value of $156,840.00. Following the completion of the transaction, the insider owned 28,436 shares of the company's stock, valued at approximately $4,459,902.24. This trade represents a 3.40% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 120,181 shares of company stock valued at $18,918,012. 0.20% of the stock is currently owned by corporate insiders.

Wall Street Analyst Weigh In

Several equities research analysts have commented on the stock. Berenberg Bank increased their price objective on shares of Procter & Gamble from $152.00 to $154.00 and gave the company a "hold" rating in a research note on Wednesday, September 17th. Barclays set a $164.00 target price on Procter & Gamble and gave the company an "equal weight" rating in a report on Thursday, July 31st. UBS Group set a $180.00 price target on Procter & Gamble and gave the stock a "buy" rating in a report on Wednesday, July 30th. Evercore ISI restated an "in-line" rating and issued a $170.00 price objective (down previously from $190.00) on shares of Procter & Gamble in a research note on Monday, July 14th. Finally, BNP Paribas Exane decreased their target price on Procter & Gamble from $177.00 to $172.00 and set an "outperform" rating for the company in a research report on Tuesday, September 23rd. One investment analyst has rated the stock with a Strong Buy rating, eleven have given a Buy rating and eight have issued a Hold rating to the stock. According to data from MarketBeat, the company presently has an average rating of "Moderate Buy" and an average target price of $173.68.

Procter & Gamble Trading Up 0.6%

Shares of PG opened at $153.42 on Tuesday. Procter & Gamble Company has a fifty-two week low of $149.91 and a fifty-two week high of $180.43. The business has a 50-day moving average of $155.97 and a 200 day moving average of $160.39. The firm has a market cap of $359.08 billion, a P/E ratio of 23.57, a price-to-earnings-growth ratio of 4.02 and a beta of 0.36. The company has a debt-to-equity ratio of 0.49, a quick ratio of 0.49 and a current ratio of 0.70.

Procter & Gamble (NYSE:PG - Get Free Report) last issued its earnings results on Tuesday, July 29th. The company reported $1.48 earnings per share for the quarter, topping analysts' consensus estimates of $1.42 by $0.06. The firm had revenue of $20.89 billion during the quarter, compared to analyst estimates of $20.79 billion. Procter & Gamble had a net margin of 18.95% and a return on equity of 32.69%. The company's quarterly revenue was up 1.7% on a year-over-year basis. During the same quarter last year, the business earned $1.40 earnings per share. Procter & Gamble has set its FY 2026 guidance at 6.830-7.090 EPS. As a group, research analysts forecast that Procter & Gamble Company will post 6.91 EPS for the current year.

Procter & Gamble Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Friday, August 15th. Shareholders of record on Friday, July 18th were issued a dividend of $1.0568 per share. The ex-dividend date of this dividend was Friday, July 18th. This represents a $4.23 dividend on an annualized basis and a yield of 2.8%. Procter & Gamble's payout ratio is presently 64.82%.

Procter & Gamble Company Profile

Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.

Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Procter & Gamble Company (The) (NYSE:PG - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.